Back to News
Market Impact: 0.18
Vivos Therapeutics Advances South Florida Sleep Center With South Palm Cardiovascular Partnership
Source: Nasdaq
Healthcare & BiotechCompany FundamentalsM&A & Restructuring
Vivos Therapeutics (VVOS) announced definitive collaboration and operating agreements with South Palm Cardiovascular Associates (SPCVA) to establish a (truncated in article). The news signals progress on partnerships in its obstructive sleep apnea and breathing disorders focus, with likely modest impact absent additional financial terms or near-term guidance.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.12
Ticker Sentiment
VVOS0.25
More News
- ‘If nothing is done, it’s almost inevitable’: Ukraine’s Yuriy Ryzhenkov on why steelmaking is on the brink of collapse as Russian bombing intensifies
- Why is LG Innotek stock plunging today?
- TotalEnergies, KKR expand U.S. solar venture with 700 MW addition
- TikTok CEO sees major scientific breakthroughs from AI within three years
- Vår Energi cuts 2026 output forecast; Q3 production at 369,000 boepd
- TSMC expected to report sixth straight quarter of record profit thanks to AI boom